The core function of the Screening Group (SCR) at IARC is to provide data on the accuracy, reproducibility, efficacy, benefits, harmful effects, and cost-effectiveness of various early detection interventions for breast, cervical, colorectal, and oral cancers, among others, in reducing deaths and improving patients’ quality of life in various settings. These data can then be used to inform and improve the rational use of health-care resources. The Group’s ultimate objective is to guide the development of public health policies for implementing screening in a variety of health-care settings, in particular in low- and middle-income countries (LMICs).
SCR conducts field studies in LMICs to evaluate various early detection methods for breast, cervical, colorectal, and oral cancer control. These initiatives also address the means by which screening services could be scaled up through local public health services. SCR develops various training resources to catalyse and augment capacity building in close collaboration with national institutions and government health services. Through its research programme, SCR generates scientific evidence to support the development of resource-appropriate early detection policies and health systems for the delivery of effective early services. The Cancer Screening in 5 Continents (CanScreen5) project of the Group aims to collect information on characteristics and performance of cancer screening programmes around the world and disseminate such information for informed decision making in cancer screening programmes. For example, the Group significantly contributed also to the evaluation of the safety and efficacy of less than three doses of the HPV vaccine in protecting against cervical cancer.
EMERGENCY: Coronavirus disease (COVID-19) Pandemic16/03/2020
Regular updates on the coronavirus disease (COVID-19) outbreak are available at the WHO website.
Launch of the WHO Cervical Cancer Country Profiles17/11/2021
Today on Cervical Cancer Elimination Day of Action WHO published the WHO Cervical Cancer Country Profiles that are available to bring out the current status of cervical cancer for each WHO Member States (194 total) curated from multiple data sources. The profiles include the following information: burden of cervical cancer, primary prevention, secondary prevention and treatment and supportive care. The data presented in the profiles are derived from several sources. Visit the WHO Cervical Cancer Country Profiles.
Launch of the IARC Cervical Cancer Image Bank to aid AI cancer detection17/11/2021
The IARC Cervical Cancer Image Bank website is launched today, to accelerate innovation and ensure the quality of machine learning algorithms for the early detection of cervical precancer and cancer. The launch of this new image bank, on 17 November 2021, marks the first anniversary of the launch of the World Health Organization (WHO) Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem.
Visit the IARC Cervical Cancer Image Bank website and read IARC News.
Virtual conference: Cervical cancer elimination, day of action15/11/2021
On Wednesday 17 November 2021, the World Health Organization will mark the first anniversary of a historic movement, celebrating the first time the world has committed to eliminate a cancer.
Learn more about the Cervical Cancer Elimination movement and watch the livestream.
Virtual conference: London Global Cancer Week - Cancer Control in low and middle income countries on 15th November from 10:30 am - 3:30 pm GMT12/11/2021
London Global Cancer Week convenes leading global cancer organizations and public health agencies to review the global state of cancer, to share best practices and to set the global agenda towards the theme “Shining a light on the global cancer epidemic”. The IARC is one of the participating institutions with WHO and IAEA on 15th November from 10:30 am - 3:30 pm GMT. Following themes will be discussed: (I) Cancer control today: are we on track to achieve SDGs? (II) Effective Cancer Control Planning: Addressing the gaps (III) UN Programmes To Accelerate Implementation (IV) Implementation Research To Guide Program Scale-Up. Free registration and agenda.
|Miranda-Filho A., Charvat H., Bray F., Migowski A., Cheung L.C., Vaccarella S., Johansson M., Carvalho A.L., Robbins H.A. A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil. EClinicalMedicine. 2021 Nov 1;42:101176.|
|Bouvard V., Wentzensen N., Mackie A., Berkhof J., Brotherton J., Giorgi-Rossi P., Kupets R., Smith R., Arrossi S., Bendahhou K., Canfell K., Chirenje Z.M., Chung M.H., Del Pino M., de Sanjose S., Elfstrom M., Franco E.L., Hamashima C., Hamers F.F., Herrington C.S., Murillo R., Sangrajrang S., Sankaranarayanan R., Saraiya M., Schiffman M., Zhao F., Arbyn M., Prendiville W., Indave Ruiz B.I., Mosquera-Metcalfe I., Lauby-Secretan B. The IARC Perspective on Cervical Cancer Screening. N Engl J Med. 2021 Nov 11;385(20):1908-1918.|
|Mao J.J., Pillai G.G., Andrade C.J., Ligibel J.A., Basu P., Cohen L., Khan I.A., Mustian K.M., Puthiyedath R., Dhiman K.S., Lao L., Ghelman R., Caceres Guido P., Lopez G., Gallego-Perez D.F., Salicrup L.A. Integrative oncology: Addressing the global challenges of cancer prevention and treatment. CA Cancer J Clin. 2021 Nov 9. doi: 10.3322/caac.21706.|